Myocardial Contrast Echocardiography in Congenital Heart Disease
NCT ID: NCT00412685
Last Updated: 2015-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
45 participants
OBSERVATIONAL
2006-08-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Absolute Myocardial Perfusion Measurement in the Transplanted Heart
NCT00414895
Coronary Artery Assessement by TEE in Congenital Heart Disease
NCT04194502
Role of Echocardiography in Optimization of Cardiac Catheterization in Children With Congenital Heart Disease
NCT06324903
Prognosis in Adult Patients with Congenital Heart Disease
NCT06723704
Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)
NCT00286559
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TGA group
The TGA group consists of 15 patients treated withMustard or Senning procedures for surgical repaired of D-TGA atrial switch operation.
No interventions assigned to this group
TOF group
The TOF group consists of 15 patients with surgically corrected TOF.
No interventions assigned to this group
Control group
The control group C consists of 15 control subjects (AH) with normal Doppler Echocardiographic echocardiographic examinations.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
* Age \>= 18 years
Exclusion Criteria
* Pregnancy and breast feeding
* Diabetes mellitus
* Contraindications to stress testing (ergometry or adenosine)
* Known adverse reaction or hypersensitivity against V08DA (SonoVue) or its components or against adenosine
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Cardiology, University Hospital, CH-3010 Bern, Switzerland
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Seiler, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Berne, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Inselspital
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
70/06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.